Patents Represented by Attorney John W. Albrecht
  • Patent number: 7647121
    Abstract: Techniques for selectably providing either constant voltage or constant current stimulation are described. A programming device provides a user interface by which a user selects either constant voltage or constant current stimulation, and selects either a voltage or current amplitude based on the selected stimulation mode. The programming device configures a medical device to provide the selected mode of stimulation at the selected amplitude. For example, when a medical device has constant voltage stimulation circuitry, e.g., circuitry including a voltage source, and the user selects constant current stimulation, the programming device configures the medical device to adjust the voltage amplitude based on a measured impedance to provide substantially constant current amplitude.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: January 12, 2010
    Assignee: Medtronic, Inc.
    Inventors: Carl D. Wahlstrand, Robert M. Skime
  • Patent number: 7610099
    Abstract: An implantable medical device with a main processor also has a telemetry processor to perform some telemetry processing functions resulting under some circumstances in reducing demands on the main processor, conserving energy, increasing telemetry processing speed, and many other advantages. A wide variety of implantable medical devices can be configured with a telemetry processor including neuro stimulators, pacemakers, defibrillators, drug delivery pumps, diagnostic recorders, and cochlear implants. The telemetry processor includes control logic, a data decoder, a receive buffer, a data encoder, and a transmit buffer. Methods of receiving messages and transmitting messages with a telemetry processor are also disclosed.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: October 27, 2009
    Assignee: Medtronic, Inc.
    Inventors: Allen Dale Almendinger, Martinus A G M Bakx
  • Patent number: 7610083
    Abstract: A method and apparatus is provided for handling multiple loop recordings that result from events in a limited memory implantable device. The events may include various automatic and manual triggers. The method provides a mechanism for deciding the amount of information to store associated with each overlapping loop recording.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: October 27, 2009
    Assignee: Medtronic, Inc.
    Inventors: Touby A. Drew, David L. Carlson
  • Patent number: 7546164
    Abstract: An implantable lead for electrical stimulation of tissue has wire-like extendable members whose tips curl back upon themselves in open tissue spaces to form 2- or 3-dimensional electrodes. The electrodes may be positioned axially or in other directions from the lead body. Traction on the lead body or extendable members allows easy withdrawal as the member tip electrodes uncurl, allowing removal without major surgery. This apparatus and method is useful for minimally invasive insertion of electrodes or electrode arrays, especially through a narrow body lumen or Tuohy needle, providing therapeutic stimulation of nervous tissue, muscle or organs.
    Type: Grant
    Filed: March 19, 2004
    Date of Patent: June 9, 2009
    Assignee: Medtronic, Inc.
    Inventor: Gary William King
  • Patent number: 7421297
    Abstract: An assembly for sensing physiologic signals and delivering monopolar stimulation therapy includes a pulse generator, a lead body that is coupled to the pulse generator and includes a first lead, at least one stimulating electrode coupled to the first lead and adapted to receive stimulating pulses from the pulse generator, and a remote electrode that is coupled to the pulse generator and positioned away from the pulse generator.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: September 2, 2008
    Assignee: Medtronic, Inc.
    Inventors: Jonathon E. Giftakis, Jonathan C. Werder, Paul H. Stypulkowski
  • Patent number: 7330754
    Abstract: A stream processor for an implantable medical device provides rapid computation using simple architecture and low power in which each input data sample is processed in parallel by a separate and independent central processing unit executing similar or identical kernel code consisting of the following elements. A housing contains a power source. A controller with memory coupled to the power source. A first physiological sensing apparatus and at least a second physiological sensing apparatus is coupled to the controller. A first stream processing element is coupled to the first physiological sensor and coupled to the controller. At least a second stream processing element is coupled to the second physiological sensor and coupled to the controller.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: February 12, 2008
    Assignee: Medtronic, Inc.
    Inventor: Steven L. Jensen
  • Patent number: 7295880
    Abstract: System and method for end of battery life operation of an implantable bilateral brain stimulator. The present system and method automatically measures one or more levels of electrical parameters in a battery system of the implantable stimulator. The measurement can be compared to threshold values. The implantable bilateral brain stimulator can then make automatic adjustments to the therapy when the levels of the electrical parameters in the battery system reach the threshold values. Adjustments to the therapy are made such that the patient is provided with an adjusted, but sufficiently safe, amount of therapy so as to extend the life of the battery and also to allow some physical symptoms alleviated by the system to return, thereby signaling the patient that medical attention needs to be sought.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: November 13, 2007
    Assignee: Medtronic, Inc.
    Inventor: Frans L. H. Gielen
  • Patent number: 7146224
    Abstract: An implantable medical device for stimulating electrically excitable tissue within a patient, and more particularly relates to such a system having a pulse generator and a lead. The lead includes a first set of electrodes including at least three electrodes. The lead also includes a second set of electrodes including at least first, second and third electrodes. The first and second electrodes are positioned on opposite sides of an imaginary longitudinal axis that passes through the center of the third electrode. The second set of electrodes is located at or nearer to the proximal portion of the lead relative to the location of the first set of electrodes.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: December 5, 2006
    Assignee: Medtronic, Inc.
    Inventor: Gary W. King
  • Patent number: 7107104
    Abstract: A neural lead and method of treating neurological disorders by stimulation of the cerebral cortex of the brain is provided. The lead is designed for reduction of strain between the lead body and the lead paddle caused by the position of the lead body above the cranium and the lead paddle beneath the cranium. The lead is also designed to include a two dimensional chronic electrode array for better stimulation coverage of the target area of the cerebral cortex. A method of treating a neurological disorder by stimulating the cerebral cortex is also presented.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: September 12, 2006
    Assignee: Medtronic, Inc.
    Inventors: Yves Keravel, Jean Paul N'Guyen, Paulus Van Venrooij, Frans L. H. Gielen, Thomas E. Cross, Jr.
  • Patent number: 7006872
    Abstract: A system and method for predicting the likelihood of occurrence of an impending neurological episode. Electrical stimuli are delivered to a structure of the brain. Response field potentials evoked by the stimuli are sensed. Analysis of these field potentials allows for predictions as to the occurrence of an impending, but not yet occurring, neurological disorder. In one example, a measurement of change in response pulses is used to determine a level of interconnectivity in the structures of the brain. The level of functional interconnectivity is used in predicting the occurrence of the neurological event. An example of such a neurological event includes an epileptic seizure.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: February 28, 2006
    Assignee: Medtronic, Inc.
    Inventors: Frans L. H. Gielen, Wytse J. Wadman
  • Patent number: 7001359
    Abstract: A medical device known as an implantable therapeutic substance delivery device is configured for implanting in humans to deliver a therapeutic substance such as pharmaceutical compositions, genetic materials, and biologics to treat a variety of medical conditions such as pain, spastisity, cancer, and many other conditions. The infusion device embodiment has active longevity projection that more accurately predicts an elective replacement period for the infusion device to increase the infusion device's effective life, reduce the need for a clinician to perform static longevity forecasts for therapy changes, facilitate elective replacement scheduling for the convenience of the patient and clinician, and many other improvements. The infusion device has a housing, a power source, a therapeutic substance reservoir, a therapeutic substance pump, and electronics. Many embodiments of the therapeutic substance delivery device with active longevity projection and its methods of operation are possible.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: February 21, 2006
    Assignee: Medtronic, Inc.
    Inventor: Charles R. Rogers
  • Patent number: 6970747
    Abstract: An implantable neurological stimulation lead with improved stylet handle comprises a lead body, at least one conductor, at least one electrical contact, at least one electrode, a stylet wire, and a stylet handle. The lead body has a body proximal end, a body distal end, and a stylet lumen. The conductor is contained in the lead and extends from the body proximal end to the body distal end, and the conductor is electrically insulated. The electrical connector is carried on the body proximal end and electrically connected to the conductor. The electrode is carried on the body distal end and electrically connected to the conductor. The stylet wire is configured for insertion into the stylet lumen to stiffen the lead body. The stylet handle is selectively coupled to the stylet wire. The stylet handle has a lead carrier and at least one gripper carried in the lead carrier configured to grip the lead body at a selected point along the lead body or lead proximal end.
    Type: Grant
    Filed: January 11, 2002
    Date of Patent: November 29, 2005
    Inventors: Scott B. Kokones, Shahn S. Sage
  • Patent number: 6749581
    Abstract: A medical device known as a catheter is configured with a variable infusion rate to deliver a therapeutic substance such as pharmaceutical compositions, genetic materials, and biologics to treat a variety of medical conditions such as pain, spastisity, cancer, and other diseases in humans and other animals. The variable infusion rate catheter provides clinician with increased flexibility, versatility, and many other improvements. The variable infusion rate catheter has a Micro Electro Mechanical System (MEMS) flow restriction with a variable infusion rate. The MEMS flow restriction is fluidly coupled to the catheter to receive therapeutic substance dispensed from a therapeutic substance delivery device and restrict the therapeutic substance flow to a desired infusion rate. Many embodiments of the variable infusion rate catheter and its methods of operation are possible.
    Type: Grant
    Filed: February 2, 2001
    Date of Patent: June 15, 2004
    Assignee: Medtronic, Inc.
    Inventors: David L. Thompson, Michael F. Mattes, Lary R. Larson, Kenneth T. Heruth
  • Patent number: 6671555
    Abstract: A system and method for predicting the likelihood of occurrence of an impending neurological episode. Electrical stimuli are delivered to a structure of the brain. Response field potentials evoked by the stimuli are sensed. Analysis of these field potentials allows for predictions as to the occurrence of an impending, but not yet occurring, neurological disorder. In one example, a measurement of change in response pulses is used to determine a level of interconnectivity in the structures of the brain. The level of functional interconnectivity is used in predicting the occurrence of the neurological event. An example of such a neurological event includes an epileptic seizure.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: December 30, 2003
    Assignee: Medtronic, Inc.
    Inventors: Frans L. H. Gielen, Wytse J. Wadman
  • Patent number: 6663609
    Abstract: A device and method configured for placement into the catheter access port to prevent insertion of a needle into the catheter access port. The device a prong to engage the housing and lock itself in the catheter access port, an annular surface having geometry complimentary to the catheter access port to seal the denial device, and a face configured to deny needle access to the catheter access port. The device is also self sealing to substantial prevent deposition between itself and the catheter access port, is configured to be inserted without the need for tools, and is manufactured from biocompatible material. The method for inserting this device consists of aligning the device with the catheter access port, inserting the device, confirming it is in place, and sealing it into the catheter access port.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: December 16, 2003
    Assignee: Medtronic, Inc.
    Inventors: Shobha Devi Williamson, Chris C. Christiansen, Laura Sue McWilliam
  • Patent number: 6629954
    Abstract: A medical device and more particularly a drug delivery pump has an hydraulic reservoir, a metering device, a displacement reservoir, a drug reservoir, and a drug infusion port all contained in a housing that can either be attached to or implanted into a patient. The hydraulic reservoir contains an hydraulic fluid that is under compression and flows through the metering device at an hydraulic rate. The hydraulic metering is isolated from the drug, and the metering device does not contain moving parts. The hydraulic fluid then flows into the displacement reservoir that applies pressure to the drug reservoir. The drug reservoir is compressible and adapted to contain a drug. As the drug reservoir is compressed, drug egresses through the drug infusion port at an infusion rate that is controlled by hydraulic rate. A method for filling the drug pump and a method for infusing drug from the drug pump are also disclosed.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: October 7, 2003
    Assignee: Medtronic, Inc.
    Inventor: Kenneth T. Heruth
  • Patent number: D474543
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: May 13, 2003
    Assignee: Medtronic, Inc.
    Inventors: David Warren Lee, William Hastings Wurz
  • Patent number: D479877
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: September 23, 2003
    Assignee: Medtronic, Inc.
    Inventors: David Warren Lee, William Hastings Wurz
  • Patent number: D484246
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: December 23, 2003
    Assignee: Medtronic, Inc.
    Inventors: David Warren Lee, William Hastings Wurz